171083 Ivermectin 1% / Metronidazole 1% / Niacinamide 4%
FDA Label NDC 72934-1237

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product 171083 Ivermectin 1% / Metronidazole 1% / Niacinamide 4% (NDC 72934-1237). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions for use, sincerus florida, llc adverse reactions, active, inactive, ndc 72934-1237-2 171083 ivermectin 1% / metronidazole 1% / niacinamide 4% gel 30 gm, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Directions For Use

→ Sincerus Florida, Llc Adverse Reactions

→ Active, Inactive

→ Ndc 72934-1237-2 171083 Ivermectin 1% / Metronidazole 1% / Niacinamide 4% Gel 30 Gm

* Please review the disclaimer below.

Previous Product 72934-1212

Next Product 72934-2008